Skip to main content
SpringerLink
Log in

The effect of rectal and nasal administration of salmon calcitonin in normal subjects

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

In order to ascertain the blood levels and the biologic responses obtained after administration of two noninjectable forms of salmon calcitonin (SCT) (i.e., a nasal spray and a suppository), two doses of 200 IU each were administered at 3 hour intervals nasally to 8 normal subjects, and rectally to 9 normal subjects. Five untreated subjects served as controls. All were given a standardized diet for 2 days before the test. Plasma salmoncalcitonin, ionized calcium, phosphate, sodium, proteins, creatinine, and alkaline phosphatase were measured repeatedly after the administration of the drug. Modifications in fractionated urinary calcium, phosphate, sodium, and creatinine excretions (and hydroxyproline for the 8 subjects treated by the nasal spray) were compared with the values measured on the previous day. Plasma concentrations of SCT were found to increase sharply with both routes of administration, the peaks being high and short after rectal administration, low but more sustained after nasal application. Despite these differences, almost similar biologic effects could be demonstrated: transient hypocalcemia, increased calciuria, phosphaturia, and natriuria. Urinary hydroxyproline excretion decreased. Plasma sodium did not increase, whereas it did in the controls. In conclusion, nasal sprays and suppositories of SCT appear to exert the known biologic effects of SCT, and might be favored for long-term treatment in diseases representing indications for calcitonin therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Avioli LV (1985) The benefits of long-term calcitonin treatment in Paget's disease of bone. In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam, (ICS Nr 663), p. 325

    Google Scholar 

  2. De Rose J, Singer FR, Avramides A, Flores A, Dziadiw R, Baker RK, Wallach S (1974) Response of Paget's disease to porcine and salmon calcitonin: effects of long-term treatment. Am J Med 56:858

    Article  Google Scholar 

  3. Kanis JA, Horn DB, Scott RDM, Strong JA (1974) Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J 3:727

    PubMed  CAS  Google Scholar 

  4. Deftos LJ, First BP (1981) Calcitonin as a drug. Ann Intern Med 95:192

    PubMed  CAS  Google Scholar 

  5. Avioli LV (1985) Osteoporosis and calcitonin therapy: a new horizon. In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam (ICS Nr 663), p. 137

    Google Scholar 

  6. Chesnut CH (1981) Calcitonin in the treatment of postmenopausal osteoporosis. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam (ICS Nr 540), p. 153

    Google Scholar 

  7. Agrawal R, Wallach S, Cohn S, Tessier M, Verch R, Hussain M, Zanzi I (1981) Calcitonin treatment of osteoporosis In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam (ICS Nr 663), p 337

    Google Scholar 

  8. Baud CA, De Siebenthal J, Langer B, Tupling MR, Mach S (1970) The effects of prolonged administration of thyrocalcitonin in human senile osteoporosis. In: Taylor SF (ed) Calcitonin 1969. Heinemann, London, p 540

    Google Scholar 

  9. Jowsey J, Riggs BL, Kelly PJ, Hoffmann DL (1978) Calcium and salmon calcitonin in treatment of osteoporosis. J Clin Endocrinol Metab 47:633

    PubMed  CAS  Google Scholar 

  10. The Medical Letter (1985) Synthetic calcitonin for postmenopausal osteoporosis. Medical Letter 27:53–54

    Google Scholar 

  11. Salzman R, Manson JE, Griffing GT, Kimmerle R, Ruderman N, McCall A, Stoltz EI, Mullin C, Small D, Armstrong J, Melby JC (1985) Intranasal aeorosolized insulin: mixed-meal studies and long-term use in type I diabetes. N Engl J Med 312:1078

    Article  PubMed  CAS  Google Scholar 

  12. Yamasaki Y, Schichiri M, Kawamori R, Kikuchi M, Yagi T, Arai S, Tohdo R, Hakui N, Oji N, Abe H (1981) The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects. Diabetes Care 4:454

    PubMed  CAS  Google Scholar 

  13. Guttmann S (1981) Chemistry and structure-activity relationships of natural and synthetic calcitonin. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam (ICS Nr 540) p 11

    Google Scholar 

  14. Nuesch E, Schmidt R (1981) Comparative pharmacokinetics of calcitonins. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam (ICS Nr 540), p 352

    Google Scholar 

  15. Ziegler R, Holz G, Raue F, Streibl W (1979) Nasal application of human calcitonin in Paget's disease of bone. In: McIntyre I (ed) Molecular endocrinology. Elsevier, Amsterdam p 293

    Google Scholar 

  16. Kivirikko KI, Laitinen O, Prockop DJ (1967) Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19:429

    Article  Google Scholar 

  17. Beveridge T, Niederer W, Nuesch E, Petrin A (1976) Pharmacokinetic studies with synthetic salmon calcitonin. Gastroenterol 10:12

    Google Scholar 

  18. Chierichetti SM, Gennari C, Piolini M, Nami R, Agnusdei D, Civitelli R (1985) Comparative biological activities of different calcitonins in man. In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam (ICS Nr 663) p 173

    Google Scholar 

  19. Segre G, Bruni G, Dal Pra P (1985) Calcitonin pharmacokinetics. In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam (ICS Nr 663) p 99

    Google Scholar 

  20. Langer B, Peytremann A, Rufener C, Jenny M (1971) Effets comparés de l' administration d'une dose unique de calcitonine synthétique (de type humain et de type saumon) chez l'homme normal et les sujets atteints de maladie de Paget ou d'hypercalcémie. Schweiz Med Wochenschr 101:69

    PubMed  CAS  Google Scholar 

  21. Gennari C, Chierichetti SM, Vibelli C, Francini G, Maioli E, Gonnelli S (1981) Acute effects of salmon, human and porcine calcitonin on plasma calcium and cyclic amp levels in man. Curr Ther Res 30:1025

    Google Scholar 

  22. Singer FR, Keutmann HT, Neer R, Potts JT, Krane SM (1972) Pharmacological effects of salmon calcitonin in man. In: Talmage RV (ed) Parathyroid hormone and the calcitonins. Excerpta Medica, Amsterdam, p 89

    Google Scholar 

  23. Paillard F, Ardaillou R, Malendin H, Fillastre JP, Prier S (1972) Renal effects of salmon calcitonin in man. J Lab Clin Med 80:200

    PubMed  CAS  Google Scholar 

  24. Ardaillou R, Fillastre JP, Milhaud G, Rousselet F, Delaunay F, Richet G (1969) Renal excretion of phosphate, calcium and sodium during and after a prolonged thyrocalcitonin infusion in man. Proc. Soc Exp Biol Med 131:56

    PubMed  CAS  Google Scholar 

  25. Ardaillou R, Vuagnat P, Milhaud G, Richet G (1967) Effects de la thyrocalcitonine sur l'excrétion rénale des phosphates, du calcium et des ions H+ chez l'homme. Nephron 4:298

    Article  PubMed  CAS  Google Scholar 

  26. Sjoberg HE, Granberg PO, Hjern B (1980) Calcitonin in hypercalcemic conditions. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam (ICS Nr 540) p 269

    Google Scholar 

  27. Nagant de Deuxchaisnes C, Devogelear JP, Huaux JP, Dufour JP, Depresseux G, Esselinckx W (1985) Effects of a nasal spray of salmon calcitonin in normal subjects and in patients with Paget's disease of bone. In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam (ICS Nr 663) p 329

    Google Scholar 

  28. Milhaud G, Li Tsieng-Ming, Nesralla H, Moukhtar MS, Perault-Staub AM (1968) Studies on the mode of action and the therapeutic use of thyrocalcitonin. In: Taylor SF (ed) Calcitonin 1967. Heinemann, London, p 347

    Google Scholar 

  29. Markowitz M, Rotkin L, Rosen J (1981) Circadian rhythms of blood minerals in human. Science 312:672

    Article  Google Scholar 

  30. Ishida M, Seino Y, Yamaoka K, Tanaka Y, Satomura K, Kurose Y, Yabunchi H (1983) The circadian rhythms of blood-ionized calcium in human: diurnal variation. Scand J Clin Lab Invest 43;S165:83

    Article  CAS  Google Scholar 

  31. Halloran BP, Portale AA, Castro M, Morris RC, Goldsmith RS (1985) Serum concentration of 1,25-dihydroxyvitamin D in human: diurnal variation. J Clin Endocrinol Metab 60:1104

    Article  PubMed  CAS  Google Scholar 

  32. Bijvoet OLM, Van der Sluys J, De Vries HR, Van Koppen ATJ (1971) Natriuretic effect of calcitonin in man. N Engl J Med 284:681

    Article  PubMed  CAS  Google Scholar 

  33. Prockop DJ, Kivirikko KI (1967) Relationship of hydroxyproline excretion in urine to collagen metabolism. Ann Intern Med 66:1243

    CAS  Google Scholar 

  34. Krane SM, Harris ED, Singer FR, Potts JT (1973) Acute effects of calcitonin on bone formation in man. Metabolism 22:51

    Article  PubMed  CAS  Google Scholar 

  35. Reginster JY, Albert A, Franchimont P (1985) Salmon calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients. Calcified Tissue Int 37:577

    CAS  Google Scholar 

  36. Sjoberg HE, Torring O, Bucht E (1985) Calcitonin in hypercalcemic states. II. Treatment parenterally and with a nasal spray. In: Pecile A (ed) Calcitonin 1984. Elsevier, Amsterdam (ICS Nr 663) p 371

    Google Scholar 

  37. Thiébaud D, Burckhardt P, Jaeger P, Azria M, (1987) Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia. Am J Med 82:745

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital, CH-1011, Lausanne

    T. Buclin, J. P. Randin, A. F. Jacquet, F. Gomez & P. Burckhardt

  2. Sandoz Laboratories, Basle, Switzerland

    M. Azria & M. Attinger

Authors
  1. T. Buclin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. P. Randin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. F. Jacquet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Azria
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Attinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Burckhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buclin, T., Randin, J.P., Jacquet, A.F. et al. The effect of rectal and nasal administration of salmon calcitonin in normal subjects. Calcif Tissue Int 41, 252–258 (1987). https://doi.org/10.1007/BF02555225

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02555225

Key words

Search

Navigation